![](/img/cover-not-exists.png)
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
Kong, Jee Hyun, Winton, Elliott F., Heffner, Leonard T., Chen, Zhengjia, Langston, Amelia A., Hill, Brittany, Arellano, Martha, El-Rassi, Fuad, Kim, Audrey, Jillella, Anand, Kota, Vamsi K., Bodó, ImreLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.30608
Date:
February, 2017
File:
PDF, 189 KB
english, 2017